| Bioactivity | Urease-IN-12 (compound 5e) is a competitive urease inhibitor (IC50: 0.35 μM) with the potential to inhibit gastritis and peptic ulcer caused by Helicobacter pylori[1]. |
| Target | 0.35 μM (Urease) |
| Name | Urease-IN-12 |
| Formula | C11H13ClN2O3S |
| Molar Mass | 288.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Montazer MN, et al. Design, synthesis, and biological studies of the new cysteine-N-arylacetamide derivatives as a potent urease inhibitor. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):305-315. |